Correction to: Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes (Lipids in Health and Disease, (2011), 10, 1, (120), 10.1186/1476-511X-10-120);Chronic administration of palmitoleic acid reduces insulin resistance and hepatic lipid accumulation in KK-Ay Mice with genetic type 2 diabetes

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Yang, Zhi Hong ^a   Miyahara, Hiroko ^a   Hatanaka, Akimasa ^a  

^a NIPPON SUISAN KAISHA LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; FAS ANTIGEN; MESSENGER RNA; PALMITIC ACID; PALMITOLEIC ACID; RESISTIN; STEAROYL COA DESATURASE 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOCYTOKINE; FATTY ACID SYNTHASE; LIPID; MONOUNSATURATED FATTY ACID; SCD1 PROTEIN, MOUSE; SREBF1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FOOD INTAKE; GENETIC DISORDER; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID STORAGE; LIVER WEIGHT; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; RISK FACTOR; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD; DRUG SCREENING; EXPERIMENTAL DIABETES MELLITUS; FATTY LIVER; GENE EXPRESSION; GENETICS; GLUCOSE BLOOD LEVEL; LIPID METABOLISM; LIVER; METABOLISM; ORGAN SIZE; PATHOLOGY;

MUS;

ADIPOKINES; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG EVALUATION, PRECLINICAL; FATTY ACID SYNTHETASE COMPLEX; FATTY ACIDS, MONOUNSATURATED; FATTY LIVER; GENE EXPRESSION; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; LIVER; MALE; MICE; ORGAN SIZE; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 79960555125     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-021-01513-w     Document Type: Erratum

References (42)

1. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. DeFronzo RA Ferrannini E, Diabetes Care 1991 14 173 194 10.2337/diacare.14.3. 173 2044434
2. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils. Misra A Singhal N Khurana L,, J Am Coll Nutr 2010 29 289S 301S 20823489
3. Dietary fats and prevention of type 2 diabetes. Risérus U Willett WC Hu FB,, Prog Lipid Res 2009 48 44 51 10.1016/j.plipres.2008.10.002 19032965
4. Fatty acid composition of lipids in sea buckthorn (Hippopha rhamnoides L.) berries of different origins. Yang B Kallio HP, J Agric Food Chem 2001 49 1939 1947 10.1021/jf001059s 11308350 (Pubitemid 32816842)
5. Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Maguire LS O'Sullivan SM Galvin K O'Connor TP, O'Brien NM,, Int J Food Sci Nutr 2004 5 171 178 (Pubitemid 38996828)
6. Fat content and fatty acid compositions of 34 marine water fish species from the Mediterranean Sea. Ozogul Y Ozogul F Cicek E Polat A, Kuley E,, Int J Food Sci Nutr 2008 29 1 12
7. Unsaturated fatty acids as cytoprotective agents in the pancreatic beta-cell. Morgan NG Dhayal S, Prostaglandins Leukot Essent Fatty Acids 2010 82 231 236 10.1016/j.plefa.2010.02.018 20206490
8. Unsaturated fatty acids as cytoprotective agents in the pancreatic beta-cell. Morgan NG Dhayal S, Diakogiannaki E Welters HJ, Biochem Soc Trans 2008 36 905 908 10.1042/BST0360905 18793159
9. Effects of dietary palmitoleic acid on plasma lipoprotein profile and aortic cholesterol accumulation are similar to those of other unsaturated fatty acids in the F1B golden Syrian hamster. Matthan NR Dillard A Lecker JL Ip B, Lichtenstein AH,, J Nutr 2009 139 215 221 19106316
10. A macadamia nut-rich diet reduces total and LDL-cholesterol in mildly hypercholesterolemic men and women. Griel AE Cao Y, Bagshaw DD Cifelli AM, Holub B Kris-Etherton PM, J Nutr 2008 138 761 767 18356332 (Pubitemid 351469421)
11. Macadamia nut consumption lowers plasma total and LDL cholesterol levels in hypercholesterolemic men. Garg ML Blake RJ Wills RB,, J Nutr 2003 133 1060 1063 12672919 (Pubitemid 36407125)
12. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cao H Gerhold K, Mayers JR Wiest MM, Watkins SM Hotamisligil GS, Cell 2008 134 933 944 10.1016/j.cell.2008.07.048 18805087
13. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent. Fujita T Sugiyama Y Taketomi S Sohda T, Kawamatsu Y Iwatsuka H, Suzuoki Z,, Diabetes 1983 32 804 810 10.2337/diabetes.32.9.804 6354788 (Pubitemid 13038896)
14. A simple method for the isolation and purification of total lipides from animal tissues. Folch J Lees M Stanley GHS,, J Biol Chem 1956 226 497 509
15. Risk factors for type 2 diabetes mellitus. Fletcher B Gulanick M Lamendola C,, J Cardiovasc Nurs 2002 16 17 23 11800065
16. Mechanism of free fatty acid-induced insulin resistance in humans. Perseghin G Petersen KF Rothman DL Cline GW, Shulman GI,, J Clin Invest 1996 97 2859 2865 10.1172/JCI118742 8675698 (Pubitemid 26197099)
17. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Boden G, Exp Clin Endocrinol Diabetes 2003 111 121 124 12784183 (Pubitemid 36682048)
18. Differential effects of palmitate and palmitoleate on insulin action and glucose utilization in rat L6 skeletal muscle cells. Dimopoulos N Watson M, Sakamoto K Hundal HS, Biochem J 2006 399 473 481 10.1042/BJ20060244 16822230 (Pubitemid 44672638)
19. Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes. Tsuchiya Y Hatakeyama H, Emoto N Wagatsuma F, Matsushita S Kanzaki M, J Biol Chem 2010 285 34371 34381 10.1074/jbc.M110.128520 20805226
20. Regulation of adipocytokines and insulin resistance. Fasshauer M Paschke R, Diabetologia 2003 46 1594 1603 10.1007/s00125-003-1228-z 14605806 (Pubitemid 38005321)
21. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP Maachi M, Lagathu C Kim MJ, Caron M Vidal H, Capeau J Feve B, Eur Cytokine Netw 2006 17 4 12 16613757
22. Adiponectin: action, regulation and association to insulin sensitivity. Lihn AS Pedersen SB Richelsen B,, Obes Rev 2005 6 13 21 10.1111/j.1467-789X. 2005.00159.x 15655035
23. Mechanisms of TNF-alpha-induced insulin resistance. Hotamisligil GS, Exp Clin Endocrinol Diabetes 1999 107 119 125 10.1055/s-0029-1212086 10320052
24. Role of resistin in insulin sensitivity in rodents and humans. Barnes KM Miner JL, Curr Protein Rept Sci 2009 10 96 107 10.2174/138920309787315239
25. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Donath MY Halban PA, Diabetologia 2004 47 581 589 10.1007/s00125-004-1336-4 14767595 (Pubitemid 38491259)
26. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Butler AE Janson J, Bonner-Weir S Ritzel R, Rizza RA Butler PC, Diabetes 2003 52 102 110 10.2337/diabetes.52.1.102 12502499 (Pubitemid 36042113)
27. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Maedler K Oberholzer J Bucher P Spinas GA, Donath MY,, Diabetes 2003 52 726 733 10.2337/diabetes.52.3.726 12606514 (Pubitemid 36323580)
28. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Shimano H, Prog Lipid Res 2001 40 439 452 10.1016/S0163-7827(01)00010-8 11591434 (Pubitemid 32929966)
29. Interrelationships between hepatic fat and insulin resistance in non-alcoholic fatty liver disease. Lockman KA Nyirenda MJ, Curr Diabetes Rev 2010 6 341 347 10.2174/157339910793360879 20701585
30. Critical nodes in signalling pathways: insights into insulin action. Taniguchi CM Emanuelli B Kahn CR,, Nat Rev Mol Cell Biol 2006 7 85 96 16493415 (Pubitemid 43278292)
31. Nonalcoholic fatty liver disease. Angulo P, N Engl J Med 2002 346 1221 1231 10.1056/NEJMra011775 11961152
32. The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community. Holbrook TL Barrett-Connor E Wingard DL,, Int J Obes 1989 13 723 729 2583926 (Pubitemid 20004820)
33. Influences of weight loss on long-term diabetes outcomes. Aucott LS, Proc Nutr Soc 2008 67 54 59 10.1017/S0029665108006022 18234132 (Pubitemid 351185357)
34. Effects of body weight and alcohol consumption on insulin sensitivity. Paulson QX Hong J, Holcomb VB Nunez NP, Nutr J 2010 9 14 10.1186/1475-2891-9-14 20307313
35. Caloric restriction in biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. Walford RL Mock D, Verdery R MacCallum T, J Gerontol Biol Sci 2002 57 211 224 10.1093/gerona/57.6.B211
36. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Wang H Storlien LH Huang XF,, Am J Phys Med 2002 282 1352 1359
37. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Hirasawa1 A Tsumaya K Awaji T Katsuma S, Adachi T Yamada M, Sugimoto Y Miyazaki S, Tsujimoto G,, Nat Med 2004 11 90 94 15619630
38. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Oh da Y Talukdar S, Bae EJ Imamura T, Morinaga H Fan W, Li P Lu WJ, Watkins SM Olefsky JM, Cell 2010 142 687 698 10.1016/j.cell.2010.07.041 20813258
39. Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy men. Feltrin KL Little TJ Meyer JH Horowitz M, Rades T Wishart J, Feinle-Bisset C,, Am J Clin Nutr 2008 87 1181 1187 18469237 (Pubitemid 351679756)
40. Leptin gene therapy in the fight against diabetes. Wang Y Asakawa A, Inui A Kosai K, Expert Opin Biol Ther 2010 10 1405 1414 10.1517/14712598.2010.512286 20690892
41. Role of cholecystokinin in appetite control and body weight regulation. Little TJ Horowitz M Feinle-Bisset C,, Obes Rev 2005 6 297 306 10.1111/j.1467-789X.2005.00212.x 16246215 (Pubitemid 41578599)
42. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Ahrén B, Nat Rev Drug Discov 2009 8 369 385 10.1038/nrd2782 19365392